Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: -1.00 (-0.13%)
Spread: 0.20 (0.027%)
Open: 756.00
High: 767.00
Low: 748.00
Prev. Close: 756.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SCPLC Consent Solicitation Results

28 Oct 2021 11:00

RNS Number : 5881Q
Standard Chartered PLC
28 October 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (A) IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES" OR THE "U.S.") OR TO ANY "U.S. PERSON" AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OTHER THAN A "QUALIFIED INSTITUTIONAL BUYER" AS DEFINED IN RULE 144A UNDER THE SECURITES ACT ("RULE 144A") OR (B) IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

Standard Chartered PLC 28 October 2021

STANDARD CHARTERED PLC(a public limited company incorporated in England and Wales) (the "Issuer")

On 4 October 2021, the Issuer announced invitations to the holders of the outstanding 2016 USD AT1 Securities, 2017 USD AT1 Securities and 2019 SGD AT1 Securities (as defined below, each a "Series" and together, the "Securities", the holders of which being the "Securityholders") to consent to the modification of the applicable terms and conditions of each Series (the "Conditions") such that the subordination provisions in the Conditions of such Securities align with the subordination provisions in the terms and conditions of the more recent issues of Additional Tier 1 Capital (the "Recent AT1 Securities") by the Issuer (such proposal, to the extent it relates to a Series, the "Proposal" in respect of that Series, and together the "Proposals").

Description of Securities

Rule 144A ISIN / Common Code / CUSIP

Reg S ISIN /Common Code

First Call Date

U.S.$2,000,000,000 7.50 per cent. Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (the "2016 USD AT1 Securities")

US853254BA77 / 147574614 / 853254 BA7/G84228 CQ9

USG84228CQ91 / 147574690

2 April 2022

U.S.$1,000,000,000 7.75 per cent. Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (the "2017 USD AT1 Securities")

US853254BH21 / 155097418 / 853254 BH2/G84228 CX4

USG84228CX43 / 155097477

2 April 2023

SGD 750,000,000 5.375 per cent. Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (the "2019 SGD AT1 Securities")

N/A / N/A / N/A

XS2013525253 / 201352525

3 October 2024

This announcement does not contain the full terms and conditions of the Proposals, which were contained in the Consent Solicitation Memorandum dated 4 October 2021 (the "Consent Solicitation Memorandum") prepared by the Issuer. Capitalised terms used in this announcement have the meanings given in the Consent Solicitation Memorandum.

Results of the Meetings

Separate Meetings were held via teleconference on 28 October 2021 in connection with the Proposals, and the Issuer hereby announces that at each Meeting:

(i) the necessary quorum was achieved;

(ii) the relevant Extraordinary Resolution was duly passed; and

(iii) the Eligibility Condition was satisfied.

In accordance with the indicative timetable set out in the Consent Solicitation Memorandum, each Supplemental Trust Deed was entered into on 28 October 2021 to effect the changes to the Conditions contemplated in each of the relevant Extraordinary Resolutions. The relevant Consent Fee shall be paid to the relevant Eligible Securityholders and the relevant Ineligible Securityholder Payment shall be paid to the relevant Ineligible Securityholders, with such payments expected to be made on 28 October 2021.

For further information, please contact:

THE SOLICITATION AGENTS

J.P. Morgan Securities LLC* 383 Madison AvenueNew York, New York 10179USA

Telephone: +1 (866) 834-4666

Email: JPM_LM@jpmorgan.com

J.P. Morgan Securities plc**25 Bank StreetLondon E14 5JPUnited Kingdom

Telephone: +44 (0)20 7134 2468

Email: liability_management_EMEA@jpmorgan.com

Attention: EMEA Liability Management Group

 

Morgan Stanley & Co. LLC1585 Broadway, 29th FloorNew York, New York 10036USA

Telephone: +1 (866) 718 1649 /+44 (0)20 7677 5040

Email: lmgny@morganstanley.com / liabilitymanagementeurope@morganstanley.com

Standard Chartered Bank1 Basinghall AvenueLondon EC2V 5DDUnited KingdomTelephone: +1 (212) 667 0351 / +44 (0)20 7885 5739 / +852 3983 8658 / +65 6557 8286

Email: liability_management@sc.com

 

THE INFORMATION AND TABULATION AGENT Morrow Sodali Limited

In London:103 Wigmore StreetLondon W1U 1QSUnited Kingdom

Telephone: +44 20 4513 6933

In Stamford:470 West Ave.,Suite 3000, Stamford,CT 06902United States

Telephone: +1 203 609 4910

In Hong Kong:Unit 23-016,LKF Tower,33 Wyndham Street, CentralHong Kong

Telephone: +852 2319 4130

Email: sc@investor.morrowsodali.comConsent Website: https://bonds.morrowsodali.com/sc

*In respect of the Proposals in respect of the 2016 USD AT1 Securities and the 2017 USD AT1 Securities only.

**In respect of the Proposals in respect of the 2019 SGD AT1 Securities only.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFSAIDLTFIL
Date   Source Headline
2nd May 20242:25 pmRNSQ1 2024 Pillar 3 Disclosures
2nd May 20242:06 pmRNSPublication of Supplementary Prospectus
2nd May 20247:00 amRNS1st Quarter Results
1st May 20245:40 pmRNSTransaction in Own Shares
1st May 202412:20 pmRNSNotice of Redemption
1st May 202410:03 amRNSTotal Voting Rights
30th Apr 20245:36 pmRNSTransaction in Own Shares
29th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20245:30 pmRNSTransaction in Own Shares
26th Apr 202410:17 amRNSOverseas Regulatory Announcement
25th Apr 20245:50 pmRNSTransaction in Own Shares
24th Apr 20246:25 pmRNSPublication of a Prospectus
24th Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.